DE69831511D1 - Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke - Google Patents

Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke

Info

Publication number
DE69831511D1
DE69831511D1 DE69831511T DE69831511T DE69831511D1 DE 69831511 D1 DE69831511 D1 DE 69831511D1 DE 69831511 T DE69831511 T DE 69831511T DE 69831511 T DE69831511 T DE 69831511T DE 69831511 D1 DE69831511 D1 DE 69831511D1
Authority
DE
Germany
Prior art keywords
microparticles
tip
blood brain
medicinal products
brain disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69831511T
Other languages
English (en)
Other versions
DE69831511T2 (de
Inventor
Maria Rosa Gasco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69831511D1 publication Critical patent/DE69831511D1/de
Publication of DE69831511T2 publication Critical patent/DE69831511T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis
DE69831511T 1997-12-01 1998-11-27 Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke Expired - Lifetime DE69831511T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002663A IT1296914B1 (it) 1997-12-01 1997-12-01 Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
PCT/EP1998/007664 WO1999027918A1 (en) 1997-12-01 1998-11-27 Microparticles for drug delivery across mucosa and the blood-brain barrier

Publications (2)

Publication Number Publication Date
DE69831511D1 true DE69831511D1 (de) 2005-10-13
DE69831511T2 DE69831511T2 (de) 2006-06-14

Family

ID=11378297

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831511T Expired - Lifetime DE69831511T2 (de) 1997-12-01 1998-11-27 Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke

Country Status (8)

Country Link
US (1) US6419949B1 (de)
EP (1) EP1071408B1 (de)
AT (1) ATE303799T1 (de)
AU (1) AU2155199A (de)
DE (1) DE69831511T2 (de)
ES (1) ES2247736T3 (de)
IT (1) IT1296914B1 (de)
WO (1) WO1999027918A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296914B1 (it) 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
US7153525B1 (en) 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
AU784191B2 (en) * 2000-04-11 2006-02-16 Ibergesfer, S.L. Structure for a washbasin
ES2291379T3 (es) * 2000-12-27 2008-03-01 Ares Trading S.A. Nanoparticulas lipidicas anfifilicas para la incorporacion de peptidos y/o proteinas.
US7763663B2 (en) 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
WO2003077861A2 (en) * 2002-03-13 2003-09-25 Collagenex Pharmaceuticals, Inc. Water-based delivery systems
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
JP2006518701A (ja) * 2002-05-24 2006-08-17 ネオファーム、インコーポレイティッド カルジオリピン組成物、その製造方法及び使用
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
ITMI20022323A1 (it) * 2002-10-31 2004-05-01 Maria Rosa Gasco Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
US20050101605A1 (en) * 2003-11-07 2005-05-12 Ahmed Salah U. Oral liquid formulations of methotrexate
US20070219131A1 (en) * 2004-04-15 2007-09-20 Ben-Sasson Shmuel A Compositions capable of facilitating penetration across a biological barrier
CN101084016A (zh) * 2004-04-15 2007-12-05 克艾思马有限公司 能够容易穿透生物学障碍的组合物
ITMI20041151A1 (it) * 2004-06-09 2004-09-09 Maria Rosa Gasco Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
US20090180964A1 (en) * 2005-06-24 2009-07-16 Rao Papineni Transmucosal delivery of optical, spect, multimodal,drug or biological cargo laden nanoparticle(s) in small animals or humans
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US20070154403A1 (en) * 2006-01-05 2007-07-05 Thomas Skold Oral, Pulmonary and Transmucosal Delivery Composition
US7914988B1 (en) 2006-03-31 2011-03-29 Illumina, Inc. Gene expression profiles to predict relapse of prostate cancer
EP1867323A1 (de) * 2006-06-13 2007-12-19 Farmatron Ltd. Pharmazeutische Zusammensetzungen mit verbesserter Permeation durch biologische Barrieren
US20100172842A1 (en) * 2007-05-16 2010-07-08 Yeda Research And Development Co., Ltd. At The Weizmann Institute Of Science Assessment of blood-brain barrier disruption
EP2249817B8 (de) * 2008-02-18 2012-03-21 Csir Nanoteilchen-träger zur verabreichung von arzneimitteln und verfahren zu ihrer herstellung
EP2123262A1 (de) 2008-05-20 2009-11-25 Consorzio per il Centro di Biomedica Moleculare Scrl Zum Überschreiten der Blut-Hirn-Schranke fähige Polyelektrolyt-gekapselte Gold-Nanopartikel
US20100015240A1 (en) * 2008-07-16 2010-01-21 Danielle Biggs Process for preparing microparticles containing bioactive peptides
SI2343982T1 (sl) * 2008-09-17 2017-08-31 Chiasma Inc. Farmacevtski sestavki in metode povezane z dostavo
CA2772023A1 (en) 2009-08-18 2011-02-24 Ben Gurion University Of The Negev Research And Development Authority System and method for analyzing imaging data
WO2013057697A1 (en) 2011-10-19 2013-04-25 Tel Hashomer Medical Research Infrastructure And Services Ltd. Magnetic resonance maps for analyzing tissue
EP2645099A1 (de) * 2012-03-30 2013-10-02 Phares Pharmaceutical Research N.V. Biorelevante Zusammensetzungen
WO2014174480A1 (en) 2013-04-24 2014-10-30 Tel Hashomer Medical Research Infrastructure And Services Ltd. Magnetic resonance maps for analyzing tissue
JP6091721B2 (ja) * 2014-12-19 2017-03-08 積水化学工業株式会社 製剤
CA2974196C (en) 2015-01-20 2023-12-12 TetraDerm Group LLC Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
BR112019010131A2 (pt) 2016-11-21 2019-10-08 Eirion Therapeutics Inc entrega transdérmica de agentes grandes
CN113271925B (zh) * 2019-01-07 2023-11-10 釜山大学校产学协力团 使用w/o/w型三油酸甘油酯乳液促进血脑屏障开放的药物递送平台
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
DE4131562A1 (de) 1991-09-18 1993-03-25 Medac Klinische Spezialpraep Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln)
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
US5858398A (en) * 1994-11-03 1999-01-12 Isomed Inc. Microparticular pharmaceutical compositions
IT1292142B1 (it) * 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
IT1296914B1 (it) 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera

Also Published As

Publication number Publication date
ATE303799T1 (de) 2005-09-15
EP1071408B1 (de) 2005-09-07
ITMI972663A1 (it) 1999-06-01
IT1296914B1 (it) 1999-08-03
ES2247736T3 (es) 2006-03-01
WO1999027918A1 (en) 1999-06-10
DE69831511T2 (de) 2006-06-14
EP1071408A1 (de) 2001-01-31
AU2155199A (en) 1999-06-16
US6419949B1 (en) 2002-07-16

Similar Documents

Publication Publication Date Title
DE69831511D1 (de) Mikropartikel zum transport von arzneistoffen durch die schleimhaut und die blut-hirn-schranke
AR020288A1 (es) Emulsion aceite en agua que comprende un agente biologicamente activo micronizado y un sistema emulsionante adecuado.
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
FR2755136B1 (fr) Procede de preparation de nanoparticules de methylidene malonate, nanoparticules contenant eventuellement une ou plusieurs molecules biologiquement actives et compositions pharmaceutiques les contenant
ES2104522T3 (es) Nuevo sistema de administracion de medicamento.
DK1553927T3 (da) Gel-stabiliserede, nanopartikulære aktivstof-sammensætninger
DE602005010733D1 (de) Ophthalmische emulsion mit einem immunosuppressiven mittel
BR0100424A (pt) Nanoemulsão óleo-em-água que contém lipìdios anfìfilos e um polìmero não iÈnico, composição cosmética de uso tópico, suas utilizações, processo de tratamento não terapêutico e processo para espessar as nanoemulsões óleo-em -água
CY1105771T1 (el) Φαρμακευτικες συνθεσεις εφαρμογης στον βλεννογονο
CA2330330A1 (en) Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
BR0100335A (pt) Nanoemulsão óleo-em-água à base de lipìdios anfìfilos e de polìmeros catiÈnicos, composição cosmética de uso tópico, utilizações, processo de tratamento não-terapêutico e processo para espessar as nanoemulsões óleo-em-água
MA26471A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26532A1 (fr) Derives d'amines cycliques, compositions pharmaceutiques les contenant, procede pour les preparer, et leur utilisation et tant que principe pharmaceutique agissant contre les maladies respiratoires.
UY27940A1 (es) Formulacion de anticuerpos humanos para el tratamiento de trastornos asociados con tnf-a
AR043272A1 (es) Una microparticula recubierta con una sustancia lipofilica que contiene una droga proteica o antigeno y formulaciones que la comprenden
FR2778406B1 (fr) Derives d'alpha-cetoamides, procede pour leur preparation, preparations pharmaceutiques les contenant, et leur utilisation en tant que medicaments anti-viraux
NO961363D0 (no) Nytt emulsjonspreparat
MA27037A1 (fr) Amides d'acide anthranilique avec une chaine laterale heteroarylsulfonyle, procede pour leur fabrication, leur utilisation comme medicament et comme agent de diagnostic ainsi que les preparations pharmaceutiques en contenant
DE69519685T2 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
MA26499A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
WO2002066016A3 (de) Mucoadhäsive zerfallsfähige arzneizubereitung
AR030862A1 (es) Formulaciones medicinales en aerosol
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
EP1393734A4 (de) Arzneimittel gegen darmerkrankungen
DK0945136T3 (da) Topisk lægemiddel indeholdende ciclosporin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition